Cancer treatment at Yashoda Medicity is delivered through the Ethos Therapy Platform, supported by Hypersight and Identify technologies, enabling a highly precise approach to radiation therapy. As one of the principal treatment modalities for cancer, radiation therapy is particularly important in achieving effective tumour control while minimising exposure to surrounding healthy tissues. This has been further strengthened by Adaptive Radiation Therapy, which allows continuous refinement of treatment planning based on patient-specific anatomy and tumour location.
Building on this foundation, under the guidance of Dr. Gagan Saini, the Ethos Therapy Platform is an adaptive radiation therapy system designed to enhance the delivery of personalised cancer care. It enables clinicians to visualise the treatment area through real-time imaging and modify the radiation plan whenever necessary, even during the course of treatment. Supporting this capability, Hypersight technology provides advanced in-room imaging at a significantly faster pace than conventional methods, producing high-quality, diagnostic-like images within seconds.
Complementing this, Identify technology enables precise real-time patient positioning along with motion detection, ensuring accurate beam targeting without the need for invasive localisation methods. Together, these technologies enable the Radiation Oncology team at Yashoda Medicity to deliver treatment with enhanced precision, confidence, and safety.
The platform further provides clinicians with patient-specific flexibility, allowing them to personalise treatment regimens for each case. It also supports clinical decision-making and streamlines workflows across the continuum of adaptive and conventional radiotherapy planning and delivery.
In addition, the system accommodates multiple treatment techniques, including adaptive protocols as well as IGRT, IMRT, VMAT, and SBRT within a unified framework. It also enables the integration of diagnostic MR, PET, and CT imaging into the treatment planning process. By combining these advanced capabilities, Yashoda Medicity has established a highly individualised approach to precision oncology and advanced cancer care.